相关实验视频

Updated: Jul 28, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

从多糖克雷斯 (PSK) 和多糖 (PSP) 来识别和分析反向对接的抗癌治疗标

Carlos Iván López-Gil1, Alejandro Téllez-Jurado1, Marco Antonio Velasco-Velázquez2

  • 1Department of Biotechnology, Universidad Politécnica de Pachuca, Zempoala 43830, Mexico.

Molecules (Basel, Switzerland)
|November 27, 2024
PubMed
概括

多糖K (PSK) 和多糖 (PSP) 具有抗瘤特性. 这项研究使用逆对接来揭示它们与CD73,CD59,K-RAS,BAK和BCL-2等关键蛋白质的分子相互作用.

关键词:
PSK PSK 在线播放在PSP上提供服务.在Trametes versicolor中使用.生物信息学是一种生物信息学.致癌性蛋白质的致癌性蛋白质免疫刺激剂是一种免疫刺激剂.反向对接的对接是相反的

更多相关视频

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.2K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

2.4K

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...